Cocrystal Pharma, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Cocrystal Pharma, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on July 14, 2026, to elect directors, ratify auditors, and address potential meeting adjournments.
NASDAQ
Cocrystal Pharma will hold its 2025 annual meeting of stockholders virtually on June 25, 2025, to vote on the election of directors, ratification of the company's accounting firm, approval of the 2025 Equity Incentive Plan, and a potential adjournment.
NASDAQ
Cocrystal Pharma is holding its 2025 Annual Meeting of Stockholders virtually on June 25, 2025, to vote on key proposals including the election of directors, ratification of the independent auditor, and approval of a new equity incentive plan.
NASDAQ
Cocrystal Pharma is holding its 2024 Annual Meeting of Stockholders virtually on June 25, 2024, to vote on key proposals including director elections, auditor ratification, and amendments to the Certificate of Incorporation.